Clients

Neovasc Inc.

Company Snapshot: Neovasc Inc.

NVCN
Last Change Volume High Low

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Client News

  1. Mar 2 2021 Neovasc Comments on Clinical Cardiology Journal Publication
  2. Feb 24 2021 Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
  3. Feb 24 2021 Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
  4. Feb 24 2021 Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule